Zejula, an anti-cancer drug that inhibits the ability of tumor cells to self-repair, has been approved by the Food and Drug Administration (FDA) for sale in the United States after a clinical trial showed the drug works on a broader range of cancers.
A drug approved two years ago in the United States to treat schizophrenia is undergoing review in Europe, the final step before doctors there can prescribe it some 5 million patients suffering from the disorder.
Advocating the role of big data in improving patient outcomes, Sharon B. Arnold, acting director of the Agency for Healthcare Research & Quality, recently outlined the case for expanding its use in medicine.
The Agency for Healthcare Research & Quality (AHRQ) will conduct a study to use additional technology in hospitals, with the overall goal of augmenting safety and preventing costly surgical complications.
Patients treated with Eli Lilly’s Taltz oral prescription medication for psoriasis showed better results than those receiving Janssen Biotech’s rival drug Stelara, according to an Eli Lilly press release.
Researchers at GlaxoSmithKline (GSK) have discovered that two key measures that track symptom severity among asthmatic patients considerably improved with the use of Nucala, according to the results of a clinical trial.